174 related articles for article (PubMed ID: 22224814)
1. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in apoE-deficient mice by inhibiting acyl-CoA:cholesterol acyl-transferase (ACAT).
Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Horlad H; Ikeda T; Nohara T; Takeya M; Nagai R
J Agric Food Chem; 2012 Mar; 60(10):2472-9. PubMed ID: 22224814
[TBL] [Abstract][Full Text] [Related]
2. Esculeogenin A, a new tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in ApoE-deficient mice by inhibiting ACAT.
Fujiwara Y; Kiyota N; Hori M; Matsushita S; Iijima Y; Aoki K; Shibata D; Takeya M; Ikeda T; Nohara T; Nagai R
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2400-6. PubMed ID: 17872457
[TBL] [Abstract][Full Text] [Related]
3. Manzamine A, a marine-derived alkaloid, inhibits accumulation of cholesterol ester in macrophages and suppresses hyperlipidemia and atherosclerosis in vivo.
Eguchi K; Fujiwara Y; Hayashida A; Horlad H; Kato H; Rotinsulu H; Losung F; Mangindaan RE; de Voogd NJ; Takeya M; Tsukamoto S
Bioorg Med Chem; 2013 Jul; 21(13):3831-8. PubMed ID: 23665143
[TBL] [Abstract][Full Text] [Related]
4. The tomato saponin, esculeoside A.
Nohara T; Ono M; Ikeda T; Fujiwara Y; El-Aasr M
J Nat Prod; 2010 Oct; 73(10):1734-41. PubMed ID: 20853874
[TBL] [Abstract][Full Text] [Related]
5. The extract of Ilex kudingcha inhibits atherosclerosis in apoE-deficient mice by suppressing cholesterol accumulation in macrophages.
Fujiwara Y; Okada S; Uryu K; Maru I; Komohara Y
Biosci Biotechnol Biochem; 2021 Sep; 85(10):2177-2184. PubMed ID: 34369980
[TBL] [Abstract][Full Text] [Related]
6. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
[TBL] [Abstract][Full Text] [Related]
7. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
8. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
[TBL] [Abstract][Full Text] [Related]
9. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia.
Yagyu H; Kitamine T; Osuga J; Tozawa R; Chen Z; Kaji Y; Oka T; Perrey S; Tamura Y; Ohashi K; Okazaki H; Yahagi N; Shionoiri F; Iizuka Y; Harada K; Shimano H; Yamashita H; Gotoda T; Yamada N; Ishibashi S
J Biol Chem; 2000 Jul; 275(28):21324-30. PubMed ID: 10777503
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.
Xu G; Watanabe T; Iso Y; Koba S; Sakai T; Nagashima M; Arita S; Hongo S; Ota H; Kobayashi Y; Miyazaki A; Hirano T
Circ Res; 2009 Aug; 105(5):500-10. PubMed ID: 19644050
[TBL] [Abstract][Full Text] [Related]
11. Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis.
Chang C; Dong R; Miyazaki A; Sakashita N; Zhang Y; Liu J; Guo M; Li BL; Chang TY
Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):151-6. PubMed ID: 16518538
[TBL] [Abstract][Full Text] [Related]
12. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
[TBL] [Abstract][Full Text] [Related]
13. Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein.
Tabas I; Boykow GC
J Biol Chem; 1987 Sep; 262(25):12175-81. PubMed ID: 3624250
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice.
Amengual J; Ogando Y; Nikain C; Quezada A; Qian K; Vaisar T; Fisher EA
Mol Pharmacol; 2021 Mar; 99(3):175-183. PubMed ID: 33384285
[TBL] [Abstract][Full Text] [Related]
15. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
Rong JX; Blachford C; Feig JE; Bander I; Mayne J; Kusunoki J; Miller C; Davis M; Wilson M; Dehn S; Thorp E; Tabas I; Taubman MB; Rudel LL; Fisher EA
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):4-12. PubMed ID: 23139293
[TBL] [Abstract][Full Text] [Related]
16. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.
Ikenoya M; Yoshinaka Y; Kobayashi H; Kawamine K; Shibuya K; Sato F; Sawanobori K; Watanabe T; Miyazaki A
Atherosclerosis; 2007 Apr; 191(2):290-7. PubMed ID: 16820149
[TBL] [Abstract][Full Text] [Related]
17. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
18. 17beta-estradiol enhances the flux of cholesterol through the cholesteryl ester cycle in human macrophages.
Napolitano M; Blotta I; Montali A; Bravo E
Biosci Rep; 2001 Oct; 21(5):637-52. PubMed ID: 12168771
[TBL] [Abstract][Full Text] [Related]
19. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of acyl coenzyme A:cholesterol acyl transferase in J774 macrophages enhances down-regulation of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase and prevents low density lipoprotein-induced cholesterol accumulation.
Tabas I; Weiland DA; Tall AR
J Biol Chem; 1986 Mar; 261(7):3147-55. PubMed ID: 3949765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
